Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KYMR | PTGX | CYTK | ||
| Company | Kymera Therapeutics Inc | Protagonist Therapeutics Inc | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 119.98 | 154.32 | 77.20 | ||
| High | 121.56 | 158.08 | 77.99 | ||
| Low | 116.46 | 149.94 | 75.65 | ||
| Last | 121.05 | 154.72 | 77.09 | ||
| Change | +1.25 | +0.40 | +0.25 | ||
| Percent Change | +1.04% | +0.26% | +0.33% | ||
| Volume | 466,800 | 483,300 | 1,212,200 | ||
| 20-Day Average Volume | 670,295 | 496,600 | 1,886,605 | ||
| Previous | 119.80 | 154.32 | 76.84 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 112.12 | 146.50 | 77.27 | ||
| 20-Day Raw Stochastic | 77.33% | 79.82% | 51.50% | ||
| 20-Day Relative Strength | 60.97 | 63.47 | 48.29 | ||
| Weighted Alpha | +150.38 | +145.41 | +59.06 | ||
| Today's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.30% since 08/17/26 | -2.46% since 08/17/26 | +1.61% since 08/17/26 | ||
| Low | 116.46 on 08/24/26 | 148.27 on 08/20/26 | 74.76 on 08/18/26 | ||
| High | 127.36 on 08/19/26 | 160.81 on 08/19/26 | 77.99 on 08/24/26 | ||
| 1-Month | |||||
| %Chg | +9.48% since 07/24/26 | +13.67% since 07/24/26 | -4.52% since 07/24/26 | ||
| Low | 99.52 on 08/03/26 | 130.63 on 07/30/26 | 72.12 on 08/14/26 | ||
| High | 127.36 on 08/19/26 | 160.81 on 08/19/26 | 82.41 on 07/27/26 | ||
| 3-Month | |||||
| %Chg | +53.44% since 05/22/26 | +55.98% since 05/22/26 | +0.19% since 05/22/26 | ||
| Low | 69.48 on 06/03/26 | 92.75 on 06/02/26 | 66.63 on 06/10/26 | ||
| High | 130.05 on 06/25/26 | 160.81 on 08/19/26 | 88.31 on 06/30/26 | ||
| 6-Month | |||||
| %Chg | +33.01% since 02/24/26 | +77.05% since 02/24/26 | +9.97% since 02/24/26 | ||
| Low | 69.48 on 06/03/26 | 85.60 on 02/26/26 | 58.43 on 03/13/26 | ||
| High | 130.05 on 06/25/26 | 160.81 on 08/19/26 | 88.31 on 06/30/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,961,490 | 9,985,739 | 9,561,431 | ||
| Shares Outstanding, K | 83,151 | 64,708 | 124,433 | ||
| Annual Sales, $M | 39,210,000 | 46,020,000 | 88,040,000 | ||
| Annual Net Income, $M | -311,350,000 | -130,150,000 | -784,960,000 | ||
| Last Qtr Sales, $M | 65,000,000 | 213,480,000 | 28,620,000 | ||
| Last Qtr Income, $M | -61,210,000 | 162,850,000 | -198,760,000 | ||
| 60-Month Beta | 1.95 | 1.78 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.62 on 08/05/26 | 2.29 on 08/05/26 | -1.50 on 08/06/26 | ||
| Latest Earnings Date | 11/03/26 | 11/05/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 146.30 | 0.00 | ||